2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2422
  



  

  
Submitter : 
  

  
Mrs. Miki Jarvie
  

  
Date & Time: 
  

  
12/01/2006 08:12:42
  



  

  
Organization : 
  

  
Mrs. Miki Jarvie
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I oppose any and all drug companies use of aborted fetal cell line products -  especially in light of other alternative methods that are available to them.